GILEAD SCIENCES SL
- Country
- 🇺🇸United States
- Ownership
- -
- Established
- 1994-01-01
- Employees
- -
- Market Cap
- $95.8B
Dose Escalation Study of CAL-101 in Select Relapsed or Refractory Hematologic Malignancies
- Conditions
- Chronic Lymphocytic Leukemia (CLL)Lymphoma, Non-Hodgkin (NHL)Acute Myeloid Leukemia (AML)Multiple Myeloma (MM)
- Interventions
- First Posted Date
- 2008-07-04
- Last Posted Date
- 2012-08-31
- Lead Sponsor
- Gilead Sciences
- Target Recruit Count
- 192
- Registration Number
- NCT00710528
- Locations
- 🇺🇸
Sarah Cannon Research Institute, Nashville, Tennessee, United States
🇺🇸The Sidney Kimmel Comprehensive Cancer Center at John Hopkins, Baltimore, Maryland, United States
🇺🇸Weill Medical College of Cornell, New York, New York, United States
Multicenter, Randomized, Double-Blind, Double-Dummy, Phase 3 Study of the Safety and Efficacy of Elvitegravir Versus Raltegravir
- Conditions
- HIV Infection
- Interventions
- First Posted Date
- 2008-07-02
- Last Posted Date
- 2016-05-30
- Lead Sponsor
- Gilead Sciences
- Target Recruit Count
- 724
- Registration Number
- NCT00708162
- Locations
- 🇺🇸
Whitman-Walker Clinic, Washington, District of Columbia, United States
🇺🇸Orlando Immunology Center, Orlando, Florida, United States
🇺🇸Wake Forest University Health Sciences, Winston-Salem, North Carolina, United States
CRITIC - Treatment of Candidemia and Invasive Candidiasis
- First Posted Date
- 2008-05-02
- Last Posted Date
- 2009-03-27
- Lead Sponsor
- Gilead Sciences
- Target Recruit Count
- 39
- Registration Number
- NCT00670657
- Locations
- 🇮🇹
Gilead Sciences Srl, Milan, Italy
Efficacy Study of CYT997 in Multiple Myeloma
- First Posted Date
- 2008-04-22
- Last Posted Date
- 2018-06-08
- Lead Sponsor
- Gilead Sciences
- Target Recruit Count
- 5
- Registration Number
- NCT00664378
- Locations
- 🇦🇺
The Alfred Hospital, Melbourne, Victoria, Australia
Efficacy Study of CYT997 in Combination With Carboplatin in Glioblastoma
- First Posted Date
- 2008-04-02
- Last Posted Date
- 2013-05-03
- Lead Sponsor
- Gilead Sciences
- Target Recruit Count
- 20
- Registration Number
- NCT00650949
- Locations
- 🇦🇺
Royal North Shore Hospital, St-Leonards, New South Wales, Australia
🇦🇺Flinders Medical Centre, Bedford Park, South Australia, Australia
🇦🇺Gold Coast Hospital, Southport, Queensland, Australia
Study to Evaluate Changes in Limb Fat When Switching From a Thymidine Analogue
- Conditions
- Lipodystrophy
- Interventions
- First Posted Date
- 2008-04-01
- Last Posted Date
- 2008-06-30
- Lead Sponsor
- Gilead Sciences
- Target Recruit Count
- 100
- Registration Number
- NCT00647946
- Locations
- 🇬🇧
Gilead Sciences, Abingdon, Cambridge, United Kingdom
Metabolic Impact Assessment of Tenofovir Disoproxil Fumarate on Non-HIV-1 Infected Healthy Adult Male Volunteers
- Conditions
- HIV Infections
- Interventions
- First Posted Date
- 2008-04-01
- Last Posted Date
- 2008-04-01
- Lead Sponsor
- Gilead Sciences
- Target Recruit Count
- 8
- Registration Number
- NCT00648817
- Locations
- 🇬🇧
Chelsea and Westminster Hospital, London, United Kingdom
CHARM: Chronic Hepatitis B Antihepadnaviral Resistance Mutation Study
- Conditions
- Chronic Hepatitis B
- Interventions
- Other: No intervention
- First Posted Date
- 2008-03-28
- Last Posted Date
- 2011-11-22
- Lead Sponsor
- Gilead Sciences
- Target Recruit Count
- 788
- Registration Number
- NCT00645736
- Locations
- 🇦🇺
Gilead Sciences Pty Ltd, East Melbourne, Victoria, Australia
PK Study of Tacrolimus and Cyclosporine When Co-Administered With Adefovir Dipivoxil in Post-Liver Transplant Patients
- First Posted Date
- 2008-03-27
- Last Posted Date
- 2008-04-10
- Lead Sponsor
- Gilead Sciences
- Target Recruit Count
- 16
- Registration Number
- NCT00644761
- Locations
- 🇺🇸
University of Miami, Miami, Florida, United States
🇺🇸University of California, San Francisco, San Francisco, California, United States
🇺🇸University of Pittsburgh, Pittsburgh, Pennsylvania, United States
Open Label Study of Pharmacokinetics and Safety of Dose of Adefovir Dipivoxil in Children and Adolescents With HBV
- First Posted Date
- 2008-03-27
- Last Posted Date
- 2008-03-27
- Lead Sponsor
- Gilead Sciences
- Target Recruit Count
- 47
- Registration Number
- NCT00645294
- Locations
- 🇬🇧
King's College Hospital, London, England, United Kingdom
🇩🇪Standort Lindwurmstrasse, Munchen, Germany
🇵🇱Klinika Gastroenterologii, Warszawa, Poland